Alabama Senate Committee Passes Medical Cannabis Legalization Bill

Alabama looks to join the growing list of states legalizing medical marijuana.

The Yellowhammer State’s Senate committee on Wednesday said yes to a medical marijuana legalization bill, moving it to the full floor for review, reports Marijuana Moment.

The bill, presented last week by Senator Tim Melson, passed the Senate Judiciary Committee 8-3 after a short debate. It proposes for around 20 ailments to be treated with medical cannabis, including sleep disorders, PTSD, anxiety, cancer-related cachexia, Crohn's disease and Tourette's syndrome.

Lawmakers may add ailments to the list.

The legislation would also set up an Alabama Medical Cannabis Commission with 11 members, which will manage licensing and regulations.

Patients would be restricted to purchasing up to “70 daily dosages of medical cannabis,” and only doctors who have completed a specific course and passed the exam could recommend cannabis.

The legislation also suggests a 9% gross proceeds tax on medical cannabis sales.

The legislation bans smoking, vaping, raw cannabis, candy, or baked good products, allowing only oils, topical patches, capsules, lozenges and suppositories.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisGovernmentNewsRegulationsPoliticsMarketsMediaGeneralcannabis industrycannabis salesCrohn's Diseaselegal marijuanamarijuanaMarijuana Momentmedical marijuana AlabamaMedical Marijuana Legalizationourette's syndromePTSDTim Melson
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.